Anaconda Biomed Announces Publication of ANAIS Study Results in the American Journal of Neuroradiology
Anaconda Biomed, S.L. has announced that results of the ANAIS Study, which evaluated the safety and performance of its ANA funnel catheter in the endovascular treatment of large vessel occlusion acute ischemic stroke, have been published in the American Journal of Neuroradiology. The data demonstrated high rates of reperfusion and first-pass success with a strong safety profile, supporting the ANA device as an adjunct to stent retriever thrombectomy in the treatment of acute ischemic stroke.
Anaconda Biomed Enrolls First U.S. Patient in the ATHENA Clinical Trial Evaluating ANA Funnel Catheter for Ischemic Stroke Treatment
Anaconda Biomed, S.L., a medical technology company developing next generation neurothrombectomy devices, today announced the enrollment and treatment of the first U.S. patient in its ATHENA clinical trial by Shahram Majidi, MD, Associate Professor of Neurosurgery, Neurology, and Radiology at Icahn School of Medicine at Mount Sinai, New York.
